- Today's Hot Chat Topics
- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Aggreko ShareCast News (AGK)
ShareCast News for Aggreko (AGK)
| Share Price: 1,731.00 | Bid: 1,730.00 | Ask: 1,731.00 | Change: 0.00 (0.00%) |  | ||||||
| ||||||||||
XP Power director make double purchase
Tue, 17th Apr 2012 15:59
David Hempleman-Adams, a non-executive director of power controller manufacturer XP Power, has purchased two lots of shares less than a week after the firm cautioned over its revenues.
The first purchase saw Hempleman-Adams, who joined the firm in 2008, snap up his first round of shares in the firm, buying 5,000 at 1,061.49p.
Three days later, on April 16th, he then bought an additional 4,450 shares for 1,057.70p each at a cost of £47,068, taking his total stake in the company to 9,450, or 0.05%.
Just one day before the first purchase, the company announced that group revenues in the three months to March 31st declined by 10% over the same period in 2011, with the weakness most evident in the industrial sector. In constant currency the decline was 11%.
The firm says it expects stronger revenues in the second quarter with customers placing orders at an increased rate, but warned that full year revenue is likely to be flat.
The share price has plunged over 35%, equivalent to 598p, over the past year, although it has risen 1.7%, equal to 18p, in the last week.
Top Director Buys
XP Power Ltd. (DI) (XPP)
Director name: Mr David Hempleman Adams
Amount purchased: 4,450 @ 1,057.70p
Value: £47,068
Plant Health Care (PHC)
Director name: Mr David Buckeridge
Amount purchased: 19,400 @ 54.12p
Value: £10,499
Plant Health Care (PHC)
Director name: Mr Samuel A Wauchope
Amount purchased: 19,400 @ 54.12p
Value: £10,499
Top Director Sells
Aggreko (AGK)
Director name: Mr Rupert Soames
Amount sold: 322,384 @ 2,160.00p
Value: £6,963,494
Aggreko (AGK)
Director name: Mr Angus Cockburn
Amount sold: 210,612 @ 2,160.00p
Value: £4,549,219
Aggreko (AGK)
Director name: Mr Kash Pandya
Amount sold: 210,258 @ 2,160.00p
Value: £4,541,573
Aggreko (AGK)
Director name: Mr George P Walker
Amount sold: 161,495 @ 2,160.00p
Value: £3,488,292
Aggreko (AGK)
Director name: Mr Bill Caplan
Amount sold: 130,598 @ 2,160.00p
Value: £2,820,917
Spirax-Sarco Engineering (SPX)
Director name: Mr James Whalen
Amount sold: 7,500 @ 2,112.20p
Value: £158,414
Brammer (BRAM)
Director name: Ms Christopher Short
Amount sold: 10,300 @ 351.00p
Value: £36,153
Brammer (BRAM)
Director name: Mr Ian Fraser
Amount sold: 10,000 @ 351.00p
Value: £35,100
NR
The first purchase saw Hempleman-Adams, who joined the firm in 2008, snap up his first round of shares in the firm, buying 5,000 at 1,061.49p.
Three days later, on April 16th, he then bought an additional 4,450 shares for 1,057.70p each at a cost of £47,068, taking his total stake in the company to 9,450, or 0.05%.
Just one day before the first purchase, the company announced that group revenues in the three months to March 31st declined by 10% over the same period in 2011, with the weakness most evident in the industrial sector. In constant currency the decline was 11%.
The firm says it expects stronger revenues in the second quarter with customers placing orders at an increased rate, but warned that full year revenue is likely to be flat.
The share price has plunged over 35%, equivalent to 598p, over the past year, although it has risen 1.7%, equal to 18p, in the last week.
Top Director Buys
XP Power Ltd. (DI) (XPP)
Director name: Mr David Hempleman Adams
Amount purchased: 4,450 @ 1,057.70p
Value: £47,068
Plant Health Care (PHC)
Director name: Mr David Buckeridge
Amount purchased: 19,400 @ 54.12p
Value: £10,499
Plant Health Care (PHC)
Director name: Mr Samuel A Wauchope
Amount purchased: 19,400 @ 54.12p
Value: £10,499
Top Director Sells
Aggreko (AGK)
Director name: Mr Rupert Soames
Amount sold: 322,384 @ 2,160.00p
Value: £6,963,494
Aggreko (AGK)
Director name: Mr Angus Cockburn
Amount sold: 210,612 @ 2,160.00p
Value: £4,549,219
Aggreko (AGK)
Director name: Mr Kash Pandya
Amount sold: 210,258 @ 2,160.00p
Value: £4,541,573
Aggreko (AGK)
Director name: Mr George P Walker
Amount sold: 161,495 @ 2,160.00p
Value: £3,488,292
Aggreko (AGK)
Director name: Mr Bill Caplan
Amount sold: 130,598 @ 2,160.00p
Value: £2,820,917
Spirax-Sarco Engineering (SPX)
Director name: Mr James Whalen
Amount sold: 7,500 @ 2,112.20p
Value: £158,414
Brammer (BRAM)
Director name: Ms Christopher Short
Amount sold: 10,300 @ 351.00p
Value: £36,153
Brammer (BRAM)
Director name: Mr Ian Fraser
Amount sold: 10,000 @ 351.00p
Value: £35,100
NR
FTSE 100 movers: Standard Life soars after beating analyst expectations
Insurance giant Standard Life was a strong riser after beating analysts' predictions in the first quarter after delivering strong sales and group assets under administration.[24 Apr '13]
London midday: Stocks flat as ECB rate cut speculation ramps up
Stocks had trimmed gains and were trading broadly flat by Wednesday lunchtime as markets gave a mixed reaction to weak economic data from Germany with traders guessing at whether the figures will prompt the European Central Bank (ECB) to cut interest rates.[24 Apr '13]
FTSE 100 movers: Johnson Matthey share lifted by Credit Suisse
Johnson Matthey shares were lifted by Credit Suisse, in which it said the speciality chemical makers is in a better position than its peers in Europe in terms of its position within the industry. The broker reiterated its 'outperform' rating on the stock.[12 Apr '13]
London midday: FTSE 100 snaps four-day winning streak
The FTSE 100 was pulling back on Friday morning after four consecutive days of gains as investors turned cautious ahead of a meeting of Eurozone finance ministers in Dublin.[12 Apr '13]
Broker tips: Aggreko, Croda, Debenhams
There will be no upgrades yet for Aggreko after a decent first quarter, but upside risk is building, according to Jefferies which reiterated its 'buy' rating and 2,200p target price for the stock.[12 Apr '13]
Broker snap: Aggreko makes 'good start' but no upgrades yet, says Jefferies
There will be no upgrades yet for Aggreko after a decent first quarter, but upside risk is building, according to Jefferies which reiterated its 'buy' rating and 2,200p target price for the stock.[12 Apr '13]
London open: Stocks fall ahead of Eurozone meeting
Renewed concerns about the Eurozone were weighing on markets on Friday morning with the FTSE 100 pulling back after four consecutive days of gains ahead of a meeting of European finance ministers later today.[12 Apr '13]
London pre-open: FTSE set to retreat ahead of bailout meeting
City sources predict the FTSE 100 will open down 26 points from yesterday's close of 6,416, as investors await the outcome of a meeting between Eurozone finance leaders - regarding the Cypriot bailout - set to take place in Dublin today.[12 Apr '13]
